Skip to content

Minister Warken Announces: Autumn Delivery of Pharmaceuticals

Medication delivery issues can arise, but they escalated significantly during the infection period towards the end of the year. Now, the Minister is addressing fresh worries.

Medicines to be distributed in the autumn, according to Minister Warken
Medicines to be distributed in the autumn, according to Minister Warken

Minister Warken Announces: Autumn Delivery of Pharmaceuticals

In recent news, the German government has announced reform plans for the healthcare system. Here's a breakdown of the key points concerning drug deliveries and the Anti-Shortage Act.

The reform plans do not mention any changes to the price rules for drug deliveries, the safety buffer requirements, or the mandatory stocks for frequently used drugs. However, they do propose giving pharmacies more leeway in acting suitable available medicines.

The Anti-Shortage Act, implemented in 2023 by the previous government, was a significant step towards addressing acute supply problems, particularly for children's medicines. The Act mandates several months' worth of stocks for frequently used drugs as a safety buffer. The Act also relaxed price rules to make drug deliveries to Germany more attractive for manufacturers.

The Anti-Shortage Act for Children's Medicines was passed by the German Bundestag in 2023, following concerns about specific supply problems with children's medicines. The Act was a response to past issues, and the minister, Nina Warken, acknowledges the public's concerns in this regard.

Health Minister Nina Warken, a CDU politician, has reassured the public that the supply of drugs is guaranteed. She has also predicted a stable supply of medicines this fall and winter. In case of shortages, she has stated that they can react promptly with appropriate measures.

The drug supply has a very high priority at both the national and European level, as stated by the minister. EU regulations will strengthen the production location in Europe, which is expected to further ensure a stable supply.

It's worth noting that the reform plans do not specify if they will affect the supply of children's medications differently. However, the minister has emphasised that the supply of children's medications has shown improvement compared to previous years.

In conclusion, while the reform plans do not make significant changes to the Anti-Shortage Act and the price rules for drug deliveries, they aim to improve pharmacy operations and ensure a stable supply of medicines. The minister's reassurances and proactive stance towards addressing shortages provide a sense of security for the public.

Read also:

Latest